|
|||||
|
|
An updated analysis of 4 randomized ECOG trials of high-dose interferon in the adjuvant treatment of melanoma |
|
| Authors: | Yana G. Najjar MD Maneka Puligandla MS Sandra J. Lee ScD John M. Kirkwood MD |
| Affiliation: | 1. Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania;2. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts |
| Abstract: | |
| Keywords: | adjuvant therapy high-dose interferon melanoma melanoma-specific survival overall survival recurrence-free survival |